Abstract
In an observational cohort study of adults living with obesity and diabetes, we found that the primary incidence of congestive heart failure was lower in patients treated with bariatric metabolic surgery than in those on first-generation GLP-1 receptor agonists, an effect that was not explained by greater weight loss in the group that received bariatric metabolic surgery.
Original language | English |
---|---|
Pages (from-to) | 2417-2418 |
Number of pages | 2 |
Journal | Nature Medicine |
Volume | 30 |
Issue number | 9 |
DOIs |
|
State | Published - Sep 2024 |